← Leaderboards
David E. Goldgar
International Agency For Res On Cancer
$2,780,341
Attributed
$7,779,526
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3M · FY2010–17$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$18,353,922 · 4
By mechanism
U19$10,574,396 · 1
R01$7,779,526 · 3
Top collaborators
- Habibul Ahsan5 shared
- Joan Siefert Brugge5 shared
- Stephen J Chanock5 shared
- Jack Cuzick5 shared
- Douglas Frederick Easton5 shared
- Matthew L Freedman5 shared
- Judy Ellen Garber5 shared
- Christopher Alan Haiman5 shared
Most similar at International Agency For Res On Cancer
Same institution · by research overlap
- Sean Vahram Tavtigian$12,922,427
- Elio Riboli$7,430,460
Others in their field
Top investigators on “Cancer Risk”
- Gregory H Reaman · National Childhood Cancer Foundation$242,495,090
- David Heimbrook · Leidos Biomedical Research, Inc.$222,048,828
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Philip J Disaia · University Of California Irvine$144,085,463
- Mitchell D Schnall · University Of Pennsylvania$138,156,012
- Peter C Adamson · National Childhood Cancer Foundation$128,266,602
Research focus
Cancer RiskWomanMalignant Breast NeoplasmVariantGenesFamily History OfInheritedHigh RiskBreastBaseBreast Cancer FamilyBrca2 GeneGeneticGene MutationIncidenceFamilyExhibitsGerm-Line MutationClinically RelevantBrca2 MutationBrca1 GeneBrca1 MutationClinical ManagementCancer-Predisposing Gene
Grant awards (18)
Risk and penetrance of mutations from breast cancer testing panels.$1,263,145
R01 · FY2017 · CA
Risk and penetrance of mutations from breast cancer testing panels.$1,299,901
R01 · FY2016 · CA
Risk and penetrance of mutations from breast cancer testing panels.$1,319,364
R01 · FY2015 · CA
A comprehensive approach to breast cancer susceptibility across the risk spectrum$19,878
R01 · FY2015 · CA · contact PI
Risk and penetrance of mutations from breast cancer testing panels.$1,408,225
R01 · FY2014 · CA
Discovery, Biology and Risk of Inherited Variants in Breast Cancer$574,120
U19 · FY2014 · CA
A comprehensive approach to breast cancer susceptibility across the risk spectrum$573,230
R01 · FY2014 · CA · contact PI
Discovery, Biology and Risk of Inherited Variants in Breast Cancer$2,309,806
U19 · FY2013 · CA
A comprehensive approach to breast cancer susceptibility across the risk spectrum$497,212
R01 · FY2013 · CA · contact PI
Discovery, Biology and Risk of Inherited Variants in Breast Cancer$2,486,910
U19 · FY2012 · CA
A comprehensive approach to breast cancer susceptibility across the risk spectrum$544,870
R01 · FY2012 · CA · contact PI
Discovery, Biology and Risk of Inherited Variants in Breast Cancer$2,465,094
U19 · FY2011 · CA
A comprehensive approach to breast cancer susceptibility across the risk spectrum$572,952
R01 · FY2011 · CA · contact PI
Discovery, Biology and Risk of Inherited Variants in Breast Cancer$2,738,466
U19 · FY2010 · CA
RISK ESTIMATION AND MODIFIER GENES IN INHERITED CANCER$72,138
R01 · FY2003 · CA
RISK ESTIMATION AND MODIFIER GENES IN INHERITED CANCER$19,089
R01 · FY2002 · CA
RISK ESTIMATION AND MODIFIER GENES IN INHERITED CANCER$88,627
R01 · FY2001 · CA
RISK ESTIMATION AND MODIFIER GENES IN INHERITED CANCER$100,895
R01 · FY2000 · CA